Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 8 points (0.0%) at 16,964 as of Wednesday, July 2, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,180 issues advancing vs. 1,847 declining with 143 unchanged. The Services sector currently is unchanged today versus the S&P 500, which is unchanged. Top gainers within the sector include Shutterfly ( SFLY), up 13.7%, Greenbrier Companies ( GBX), up 11.1%, Trinity Industries ( TRN), up 2.6%, Westinghouse Air Brake Technologies ( WAB), up 2.2% and CBS ( CBS), up 1.8%. On the negative front, top decliners within the sector include United Continental Holdings ( UAL), down 6.1%, Delta Air Lines ( DAL), down 5.5%, Golar LNG ( GLNG), down 3.3%, Ryanair Holdings ( RYAAY), down 3.2% and Paychex ( PAYX), down 2.9%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. CVS Caremark ( CVS) is one of the companies pushing the Services sector higher today. As of noon trading, CVS Caremark is up $0.44 (0.6%) to $76.48 on light volume. Thus far, 1.4 million shares of CVS Caremark exchanged hands as compared to its average daily volume of 4.6 million shares. The stock has ranged in price between $75.75-$76.73 after having opened the day at $75.99 as compared to the previous trading day's close of $76.04. CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Caremark has a market cap of $88.1 billion and is part of the retail industry. Shares are up 6.2% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate CVS Caremark a buy, no analysts rate it a sell, and 4 rate it a hold. TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full CVS Caremark Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.